To assess whether mutant and wild type IDH1 contribute to IDH1 mutated tumor cell growth, we created an IDH1 inducible knockdown cell line utilizing the fibrosarcoma cell line, HT1080 which harbors a heterozygous IDH1R132C mutation. Here, IDH1 is linked to neoplasm.